Publication | Closed Access

Dexmedetomidine alleviates cognitive impairment by reducing blood-brain barrier interruption and neuroinflammation via regulating Th1/Th2/Th17 polarization in an experimental sepsis model of mice

InflammationMedicineExperimental Sepsis ModelBrain-immune InteractionNeuroprotectionNeuroscienceBlood-brain Barrier InterruptionTh1/th2/th17 PolarizationCerebral Blood FlowPharmacologyNeuroimmunologyNeuroinflammation